These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 24700870)

  • 41. Hypertension in dialysis and kidney transplant patients.
    Prasad GV; Ruzicka M; Burns KD; Tobe SW; Lebel M
    Can J Cardiol; 2009 May; 25(5):309-14. PubMed ID: 19417862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship of volume overload and its control to hypertension in hemodialysis patients.
    Flythe JE; Bansal N
    Semin Dial; 2019 Nov; 32(6):500-506. PubMed ID: 31564065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ambulatory blood pressure monitoring and peri-hemodialysis blood pressures in a southeast US hemodialysis unit.
    Fülöp T; Schmidt DW; Cosmin A; Islam N; Wells C; Lengvárszky Z; Bilbrew DM; Zsom L
    Clin Nephrol; 2012 May; 77(5):383-91. PubMed ID: 22551884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistant Hypertension in a Dialysis Patient.
    Gallacher PJ; Farrah TE; Dominiczak AF; Touyz RM; Adamczak M; Barigou M; Zoghby Z; Hiremath S; Dhaun N
    Hypertension; 2020 Aug; 76(2):278-287. PubMed ID: 32594796
    [No Abstract]   [Full Text] [Related]  

  • 45. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-Centered Approach for Hypertension Management in End-Stage Kidney Disease: Art or Science?
    Gosmanova EO; Kovesdy CP
    Semin Nephrol; 2018 Jul; 38(4):355-368. PubMed ID: 30082056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arterial hypertension in children with end-stage renal failure treated with hemodialysis].
    Szczepańska M; Szprynger K; Adamczyk P; Trembecka-Dubel E; Oświecimska J
    Pol Merkur Lekarski; 2005 Jan; 18(103):17-21. PubMed ID: 15859540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive agents in hemodialysis patients: a current perspective.
    Inrig JK
    Semin Dial; 2010; 23(3):290-7. PubMed ID: 20374548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?
    Garg J; Bakris GL
    Am J Kidney Dis; 2003 Dec; 42(6):1301-4. PubMed ID: 14655205
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
    Agarwal R; Nissenson AR; Batlle D; Coyne DW; Trout JR; Warnock DG
    Am J Med; 2003 Sep; 115(4):291-7. PubMed ID: 12967694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertension in dialysis: pathophysiology and treatment.
    D'Amico M; Locatelli F
    J Nephrol; 2002; 15(4):438-45. PubMed ID: 12243377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drugs used in the treatment of arterial hypertension in dialysis patients in the Piedmont. What correlations between personal and clinical data can be made from the registry data?].
    Stramignoni E; Bergia R; Dionisio P; Valenti M; Berto IM; Cravero R; Agostini B; Caramello E; Piccoli GB; Bajardi P
    Minerva Urol Nefrol; 1998 Mar; 50(1):75-80. PubMed ID: 9578663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The internist's role in treating hypertension in hemodialysis patients.
    Hirsch S
    QJM; 2009 Jul; 102(7):501-7. PubMed ID: 19383610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interdialytic hypertension-an update.
    Agarwal R
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):11-6. PubMed ID: 21224025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management.
    Ok E; Levin NW; Asci G; Chazot C; Toz H; Ozkahya M
    Semin Dial; 2017 Sep; 30(5):420-429. PubMed ID: 28581677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of hypertension in dialysis patients and renal transplant recipients].
    Małyszko J; Fryc J; Myśliwiec M
    Przegl Lek; 2005; 62(7):694-7. PubMed ID: 16463704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertension and dialysis.
    Hörl MP; Hörl WH
    Kidney Blood Press Res; 2003; 26(2):76-81. PubMed ID: 12771530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistant hypertension in dialysis.
    Symonides B; Lewandowski J; Małyszko J
    Nephrol Dial Transplant; 2023 Aug; 38(9):1952-1959. PubMed ID: 36898677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.